Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd. for CNY 160 million on December 15, 2022.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.05 CNY | +1.59% | -7.24% | -36.43% |
1st Jan change | Capi. | |
---|---|---|
-36.43% | 181M | |
-3.36% | 1.38B | |
-9.76% | 1.32B | |
-15.29% | 1.07B | |
-20.70% | 845M | |
-1.15% | 463M | |
+1.81% | 434M | |
-50.00% | 373M | |
-24.35% | 335M | |
-3.26% | 210M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for CNY 160 million.